161 related articles for article (PubMed ID: 12450231)
1. Medical therapy for secondary prevention of stroke.
Regesta G
Clin Exp Hypertens; 2002; 24(7-8):555-62. PubMed ID: 12450231
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
Saxena R; Koudstaal P
Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke.
Kirshner HS
Curr Pharm Des; 2012; 18(33):5261-72. PubMed ID: 22724413
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
Koudstaal PJ
Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prevention of ischemic stroke following myocardial infarction: review of current literature.
Dutta M; Hanna E; Das P; Steinhubl SR
Cerebrovasc Dis; 2006; 22(5-6):331-9. PubMed ID: 16888371
[TBL] [Abstract][Full Text] [Related]
6. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?
Johnson P; Rosewell M; James MA
Cerebrovasc Dis; 2007; 23(2-3):156-61. PubMed ID: 17124397
[TBL] [Abstract][Full Text] [Related]
7. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
Yu HC; Tsai YF; Chen MC; Yeh CH
Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
Prisco D
Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
[No Abstract] [Full Text] [Related]
9. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
Liao JK
Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
[TBL] [Abstract][Full Text] [Related]
10. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
11. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
12. A benefit-risk assessment of agents used in the secondary prevention of stroke.
MacWalter RS; Shirley CP
Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215
[TBL] [Abstract][Full Text] [Related]
13. [Antithrombotic therapy for stroke prevention in patients with atrial fibrillation].
Tomita F; Kohya T; Kitabatake A
Nihon Rinsho; 2000 Jun; 58(6):1326-34. PubMed ID: 10879060
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
15. [Current management of antithrombotic treatment in patients with non valvular atrial fibrillation and prior history of stroke or transient ischemic attack].
Masjuán J; Álvarez-Sabín J; Blanco M; de Felipe A; Gil-Núñez A; Gállego-Culleré J; Vivancos J
Rev Neurol; 2014 Jul; 59(1):25-36. PubMed ID: 24965928
[TBL] [Abstract][Full Text] [Related]
16. Direct oral anticoagulants in the secondary prevention of stroke and transient ischemic attack in patients with atrial fibrillation.
Arnao V; Agnelli G; Paciaroni M
Intern Emerg Med; 2015 Aug; 10(5):555-60. PubMed ID: 25862436
[TBL] [Abstract][Full Text] [Related]
17. Stroke prevention.
Sudlow C; Gubitz G; Sandercock P; Lip G
Clin Evid; 2002 Jun; (7):175-98. PubMed ID: 12230643
[No Abstract] [Full Text] [Related]
18. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
Koudstaal PJ
Cochrane Database Syst Rev; 2000; (2):CD000186. PubMed ID: 10796314
[TBL] [Abstract][Full Text] [Related]
20. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
